Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $519.6M | $588.3M | $471.4M | $192.4M | $153.0M | $129.1M | $118.6M | $117.6M |
| Cost of revenue | $108.1M | $135.7M | $99.3M | $60.5M | $64.3M | $71.6M | $61.1M | $46.0M |
| Gross profit | $411.5M | $452.6M | $372.1M | $131.9M | $88.7M | $57.5M | $57.5M | $71.6M |
| Gross margin | 79.2% | 76.9% | 78.9% | 68.6% | 58.0% | 44.6% | 48.5% | 60.9% |
| R&D | $203.4M | $160.6M | $105.2M | $58.7M | $22.7M | $9.8M | $5.8M | $5.2M |
| Operating income | −$9.8M | $109.6M | $87.0M | −$116.6M | −$86.6M | −$71.3M | −$54.3M | −$23.3M |
| EBITDA | −$4.2M | −$209.5M | $53.5M | −$217.8M | −$35.8M | −$45.1M | $27.8M | −$232.8M |
| Net income | −$34.6M | −$223.4M | $33.7M | −$273.0M | −$99.6M | −$104.0M | −$65.9M | −$252.9M |
| Net margin | -6.7% | -38.0% | 7.1% | -141.9% | -65.1% | -80.5% | -55.6% | -215.0% |
| EPS (diluted) | -91.79 | -582.69 | 85.38 | -689.42 | -246.40 | -195.75 | -66.90 | -203.59 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ACORQ.
No tracked institution reports a position in ACORQ as of their last filing.
No one on the platform has traded ACORQ yet.
| $12146 |
| — |
| GNBTGenerex Biotechnology Corporation | $0.00 | +0.00% | $0 | — |
| MGFRFMagForce AG | $0.00 | +0.00% | $11973 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ACORQ BIG TIME FRAUD BY RON COHEN AND HIS CO-CONSPIRATORS!!!!
View on StockTwits ↗$ACORQ word on the street is Ron Cohen, Michael gesser and their other fraudulent associates have gone into hiding. If anyone has seen these individuals report it to law enforcement immediately. Here’s a photo of Michael Gesser.
View on StockTwits ↗$ACORQ Nothing but blatant fraud done against all shareholders.
View on StockTwits ↗$ACORQ FRAUD! “Efforts to find contact information for Cohen and Gesser, to ask for their sides of the story, failed. Acorda’s bankruptcy attorney, Blaire Cahn, did not reply to an email asking for comment.”
View on StockTwits ↗$ACORQ Milak says the executives needed to keep the share price above $1, so that Acorda would not be delisted on the Nasdaq exchange before filing for bankruptcy. He also alleges that the executives received multi-million payouts on a “backend deal they arranged for themselves.” On July 10, Merz Therapeutics, of Frankfurt, Germany, announced that it had purchased the rights to Ampyra, Inbrija and other assets for $185 million, in a bankruptcy court sale. Efforts to find contact information for Cohen and Gesser, to ask for their sides of the story, failed. Acorda’s bankruptcy attorney, Blaire Cahn, did not reply to an email asking for comment.
View on StockTwits ↗$ACORQ In 2024, a significant financial scandal emerged involving Ron Cohen and his associates at Acorda Therapeutics, in collaboration with bondholders and bankruptcy attorneys from Baker & McKenzie. Evidence has surfaced suggesting that this coordinated group orchestrated one of the most substantial frauds of the year. The intricate scheme allegedly involved deceptive financial practices, manipulation of bondholder agreements, and unethical legal maneuvers, all designed to mislead investors and stakeholders. The full extent of their actions is currently under investigation, with regulatory bodies and law enforcement agencies scrutinizing the activities of the implicated parties to ensure justice is served and to uphold the integrity of the financial and legal systems.
View on StockTwits ↗$ACORQ Ron Cohen and his associates committed one of the largest corporate FRAUDS since Bernie Madoff!!!
View on StockTwits ↗$ACORQ https://www.pharmaceutical-technology.com/news/merz-wins-185m-bid-for-bankrupt-acorda-assets-and-increases-us-workforce-by-50/ Ron Cohen is a massive fraud criminal.
View on StockTwits ↗$ACORQ Ron Cohen and Michael Gesser along with the bond holders fucked everyone good with their FRAUD! Telling investors to keep buying and they were growing all the while setting plans in motion to file chapter 11 and sell the assets of the company.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.